EFFECTIVENESS OF CERVICAL LAMINOFORAMINOTOMY FOR UNILATERAL SOFT DISC HERNIATION
DOI:
https://doi.org/10.55519/JAMC-01-13769Abstract
Background: Cervical disc herniation is one of a very few morbid and prevalent spinal condition affecting quality of life (QOL), often leading to debilitating symptoms. Early recognition of signs and symptoms is crucial for timely intervention, as conservative methods may prove insufficient in cases with neurological deficits. Surgical interventions, including the anterior and posterior and hybrid approaches, have evolved to address the challenges posed by cervical disc herniation precisely cervical spondylosis. This study explores the effectiveness of laminoforaminotomy, a targeted surgical approach for unilateral soft disc herniation. The technique aims to achieve optimal clinical outcomes by minimizing disruption to adjacent tissues and preserving motion segments. Methods: A retrospective study was conducted on 23 patients diagnosed with cervical radiculopathy who underwent posterior keyhole laminoforaminotomy between February and July 2023 at a Tertiary Care Hospital in Peshawar, Pakistan. Inclusion criteria encompassed individuals aged 30 to 70 years with persistent radicular pain, diagnosed with cervical disc herniation on MRI C spine or cervical spondylotic radiculopathy clinically. Results: The age distribution of the participants ranged from 32 to 67 years, with the largest group in the 41-50 age range. Males constituted 69.56% of the patients. The distribution of cervical disc herniations varied across levels, with the C4-C5 level exhibiting the highest occurrence. Postoperative complications were observed in 3 out of 23 patients, resulting in an 82.62% success rate. Conclusion: In summary, laminoforaminotomy demonstrates promising short term results in addressing unilateral soft disc herniation, with an 82.62% success rate portraying the need for further exploration in prospective studies for long-term efficacy.
References
1. Benson JC, Madhavan AA, Cutsforth-Gregory JK, Johnson DR, Carr CM. The Monro-Kellie Doctrine: A Review and Call for Revision. AJNR Am J Neuroradiol. 2023 Jan;44(1):2-6. doi: 10.3174/ajnr.A7721. Epub 2022 Dec 1. PMID: 36456084; PMCID: PMC9835920.
2. Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013 Oct;93(4):1847-92. [PubMed] [Reference list]
3. Preuss M, Hoffmann KT, Reiss-Zimmermann M, Hirsch W, Merkenschlager A, Meixensberger J, Dengl M. Updated physiology and pathophysiology of CSF circulation--the pulsatile vector theory. Childs Nerv Syst. 2013 Oct;29(10):1811-25. [PubMed] [Reference list]
4. Yamada, S., & Kelly, E. (2016). Cerebrospinal Fluid Dynamics and the Pathophysiology of Hydrocephalus: New Concepts. Seminars in Ultrasound, CT and MRI, 37(2), 84-91. https://doi.org/10.1053/j.sult.2016.01.001
5. Chen S, Luo J, Reis C, Manaenko A, Zhang J. Hydrocephalus after Subarachnoid Hemorrhage: Pathophysiology, Diagnosis, and Treatment. Biomed Res Int. 2017;2017:8584753. [
6. Dewan MC, Rattani A, Mekary R, Glancz LJ, Yunusa I, Baticulon RE, Fieggen G, Wellons JC, Park KB, Warf BC. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. J Neurosurg. 2018 Apr 27;130(4):1065-1079. doi: 10.3171/2017.10.JNS17439. PMID: 29701543.
7. Koleva M, De Jesus O. Hydrocephalus. [Updated 2023 Aug 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560875/
8. Faquini IV, Fonseca RB, Correia AO, Cezar Junior AB, De Carvalho Junior EV, de Almeida NS, Azevedo-Filho HRC. Endoscopic third ventriculostomy in the treatment of hydrocephalus: A 20-year retrospective analysis of 209 consecutive cases. Surg Neurol Int. 2021 Aug 3;12:383. doi: 10.25259/SNI_458_2021. PMID: 34513150; PMCID: PMC8422502.
9. Sharafat S, Khan Z, Azam F, Ali M. Frequency of success and complications of primary endoscopic third ventriculostomy in infants with obstructive hydrocephalous. Pak J Med Sci. 2022 Jan-Feb;38(1):267-270. doi: 10.12669/pjms.38.1.4097. PMID: 35035437; PMCID: PMC8713220.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asghar Ali Safi, Shahbaz Ali Khan, Ehtisham Ahmed Khan, Ahsan Aurangzeb, Fatima Javed, Haider Ali, Amir Hamza Qazi
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
